![]() Adynxx Adynxx is a biopharmaceutical company focused on bringing to market disease-modifying products for the treatment of pain and inflammation. | ![]() Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. | ![]() Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| |
Founding Date | Founding Date 2007 | Founding Date 1972 | Founding Date 2006 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ San Francisco, US | Locations Olaine, LV HQ | Locations San Diego, US HQ San Diego, US |
Employees | Employees N/A | Employees 2,191 | Employees 31019% decrease |
Valuation ($) | Valuation ($) 87.1 k | Valuation ($) N/A | Valuation ($) 1.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.2m (FY, 2018) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) $62.8m (FY, 2022) |
Cost of goods | Cost of goods $1.7m (FY, 2018) | Cost of goods €44.5m (FY, 2020) | Cost of goods N/A |
Gross profit | Gross profit $496k (FY, 2018) | Gross profit €80.1m (FY, 2020) | Gross profit N/A |
Net income | Net income ($8.4m) (FY, 2018) | Net income €9.5m (FY, 2020) | Net income ($577.8m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 23.5m | Total funding raised N/A | Total funding raised $ 42.6m |

Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
View company
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View company